期刊文献+

代谢综合征患者血清视黄醇结合蛋白4的变化及其影响因素 被引量:27

Change of serum retinol-binding protein 4 levels in subjects with metabolic syndrome and their influencing factors
原文传递
导出
摘要 目的探讨代谢综合征(MS)患者血清视黄醇结合蛋白4(RBP4)的变化及其相关影响因素。方法将2007年1~8月沈阳军区总医院门诊及住院患者60例和体检健康者20名,分为MS组31例、非代谢综合征(NMS)组29例和健康对照(C)组20例。测量体脂参数、血压,检测临床生化指标,测定血清胰岛素(FINS)、脂联素(APN)、血清RBP4、高敏C反应蛋白(hsCRP)及尿微量白蛋白(UAE)等。计算胰岛素抵抗指数(HOMA-IR)。问卷调查吸烟、饮酒习惯。结果(1)MS组血清RBP4显著高于NMS组和C组(P均<0.01),NMS组血清RBP4显著高于C组(P<0.01)。(2)男性血清RBP4显著高于女性(P<0.05)。(3)血清RBP4与体重指数(BMI)、腰围(WC)、收缩压(SBP)、舒张压(DBP)、血浆总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、lnhsCRP、lnUAE、吸烟呈显著正相关,与ANP呈显著负相关。(4)多元逐步回归分析显示,性别和BMI是血清RBP4的独立相关因素。结论MS患者血清RBP4显著升高,血清RBP4与BMI、WC、血压、脂代谢、APN、吸烟等心血管危险因素相关。 Objective To investigate the change of serum retinol binding protein 4 (RBP4) levels in subjects with metabolic syndrome ( MS), and their relationship with the components of MS. Methods Eighty subjects were enrolled and divided into different groups:MS,nonMS(NMS) and healthy controls(C). Subjects' anthropometric parameters, blood pressure,glucose and lipid metabolism parameters and insulin resistance index were measured. Serum RBP4 level, adiponectin (APN) ,high-sensitivity C-reactive protein(hsCRP) and fasting insulin(FINS) were measured. Homeostatic model assessment of insulin resistance(HOMA-IR) was calculated. A questionnaire was used to obtain participants' medical history and lifestyle information,such as smoking and alcohol ingestion habits. Results Serum RBP4 levels were significantly higher in the MS group compared with the NMS and C group. Males had significantly higher RBP4 levels than females. Serum RBP4 levels were positively correlated with BMI, WC, SBP, DBP, TC, LDL-C, lnhsCRP, lnUAE and smoking, and negatively correlated with ANP. Multiple stepwise regression anlysis showed that sex and BMI were independent related factors influencing serum RBP4 levels. Conclusion Serum RBP4 levels are significantly increased in subjects with MS. In all subjects, RBP4 is positively correlated with adiposity index ( BMI, WC ), blood pressure, lipid profile ( TC, LDL-C ) , inflammatory indice( lnhsCRP), lnUAE and smoking, and negatively correlated with ANP, which is cardiovascular disease risk factor. RBP4 is independently associated with sex and BMI.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2008年第4期267-270,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(30270537)
关键词 视黄醇结合蛋白质类 脂联素 胰岛素抵抗 代谢综合征 retinol-binding protein adiponectin insulin resistance metabolic syndrome
  • 相关文献

参考文献10

  • 1Yang Q,Graham TE Modv N,et al. Serum retinol-binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes [ J ]. Nature, 2005,436 : 356 - 362.
  • 2Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects [ J ]. N Engl J Med,2006 ,15 :354 :2552 - 2563.
  • 3Shai G, Louise MS, Patricia K, et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes [ J ]. J Clin Endocrinol Metab ,2007,92 ( 5 ) : 1886 - 1890.
  • 4Dominik GH,Karin S,Gerhard P,et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects[ J]. J Clin Endocrinol Metab,2007,92 ( 3 ) : 1168 - 1171.
  • 5宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 6Mohan V, Deepa R,Pradeepa R,et al. Association of low adiponectin levels with the metabolic syndrome - the Chennai Urban Rural Epidemiology Study ( CURES-4 ) [ J ]. Metabolism, 2005,54 ( 4 ) : 476 - 484.
  • 7Matsubara M, Katayose S, Maruoka S. Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios [ J ]. Eur J Endocrinol, 2003,148 ( 3 ) : 343 - 350.
  • 8吴海娅,贾伟平,魏丽,陆俊茜,包玉倩,项坤三.肥胖及2型糖尿病患者血清视黄醇结合蛋白4水平的变化及其临床意义[J].中华内分泌代谢杂志,2006,22(3):290-293. 被引量:95
  • 9Bell RA, Mayer-Davis EJ, Martin MA, et al. Association between alcohol consumption and insulin sensitivity and cardiovascular disease risk factor :the insulin resistance and atherosclerosis study [ J ]. Diabetes Care ,2000,23 : 1630 - 1636.
  • 10Vernay M,Balkau B.Moreau JG, et al. Alcohol consumption and insulin resistance syndrome parameters:association and evolution in a longitudinal analysis of the French DESIR cohort [ J ]. Ann Epidemiol,2004 ,14 : 209 - 214.

二级参考文献29

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献702

同被引文献324

引证文献27

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部